Brought to you by 
TargeGen closes $30mm second round
03 Feb 2004
Executive Summary
Less than two years after it completed its $10mm Series A financing, TargeGen (focused on cardiovascular diseases and cancer) has raised $30mm with its second round of funding. Co-led by new investors William Blair Capital Partners and CDP Capital Technology Ventures, existing backers including Forward Ventures, Enterprise Partners, and China Development Industrial Bank also joined in the round.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
TargeGen closes $30mm second round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice